This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Trial of Skin Care Protocols for Facial Resurfacing (SPAR)

This study has been completed.
Information provided by:
Plastic Surgery Educational Foundation Identifier:
First received: April 28, 2010
Last updated: April 29, 2010
Last verified: April 2010
The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Condition Intervention Phase
Facial Photo Damage Periocular Fine Wrinkles Perioral Fine Wrinkles Other: Obagi New-Derm System Other: Standard of Care Phase 4

Study Type: Interventional
Official Title: A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.

Further study details as provided by Plastic Surgery Educational Foundation:

Arms Assigned Interventions
Active Comparator: Obagi Nu-Derm System (ONDS) Other: Obagi New-Derm System
Active Comparator: Standard of Care Other: Standard of Care


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Female

Inclusion Criteria:

  • patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser.
  • Fitzpatrick I-IV skin types

Exclusion Criteria:

  • patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01113606

United States, California
Suite 135
Oxnard, California, United States, 93030
Suite 175
Rancho Santa Margarita, California, United States, 92688
United States, Colorado
Aesthetic and Plastic Surgery Institute
Greeley, Colorado, United States, 80634
United States, Florida
Brevard Plastic Surgery and Skin Institute
Melbourne, Florida, United States, 32901
United States, Kentucky
Kentucky Aesthetic and Plastic Surgery Institute
Louisville, Kentucky, United States, 40202
United States, Michigan
Center for Plastic and Reconstructive Surgery
Ypsilanti, Michigan, United States, 48197
United States, Missouri
Body Aesthetic Plastic Surgery
St. Louis, Missouri, United States, 63141
United States, New York
New York, New York, United States
United States, South Carolina
Advanced Cosmetis Surgery
Greenville, South Carolina, United States, 29607
Sponsors and Collaborators
Plastic Surgery Educational Foundation
  More Information Identifier: NCT01113606     History of Changes
Other Study ID Numbers: PSEF001-06
Study First Received: April 28, 2010
Last Updated: April 29, 2010

Keywords provided by Plastic Surgery Educational Foundation:
Moderate to severe facial photo damage
Periocular or perioral fine wrinkles

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes processed this record on July 21, 2017